Author | OncLive Staff | OncLive

Author | OncLive Staff


First of its Kind MMRF CureCloud Makes Way for Precision Medicine in Myeloma

July 13, 2020


In our exclusive interview, Dr. Cho and Dr. Ghobrial discuss the inspiration for the MMRF CureCloud, how it advances precision medicine, and the long-term goals of the study for patients and physicians alike.

Marvels in Medicine: Dr. Jordan on Undertaking an Unforeseen Career in Breast Cancer

July 09, 2020


In our exclusive interview, Dr. Jordan explains how he became “The Father of Tamoxifen,” details his work with British Special Forces during the Cold War, and discusses how his career in science started by setting his parents’ house on fire.

FDA Approval Insights: Ramucirumab/Erlotinib in EGFR+ Metastatic NSCLC

July 06, 2020


Edgardo S. Santos, MD, discusses the data that led to the approval of the combination of ramucirumab and erlotinib in EGFR-mutant metastatic non–small cell lung cancer and shared his thoughts on its utility in the frontline setting.

Talking KRAS-Targeted Therapy in NSCLC With Dr. Drilon

July 02, 2020


In our exclusive interview, Alexander Drilon, MD, discusses some of the historical challenges of targeting KRAS and provided perspective on available and anticipated data with AMG 510 in non–small cell lung cancer.